Dihydroxyanthraquinones and their use
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SOSEI R&D LTD
- Publication Date
- 2008-10-29
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to dihydroxyanthraquinone derivatives and their use in treating diseases. Background technique
[0002] T lymphocytes are known to play a central role in the pathogenesis of many inflammatory and autoimmune diseases. Activation of T cells by antigen-presenting cells is the initial event that initiates the inflammatory process, which subsequently leads to the activation of other inflammatory cells and subsequent release of pro-inflammatory cytokines, chemotactic agents and matrix-degrading enzymes. These cell types are also known to be essential for the initiation and maintenance of angiogenesis through secretion of VEGF. Angiogenesis-driven diseases include, but are not limited to, cancer, age-related macular degeneration, and diabetic retinopathy.
[0003] Multiple sclerosis is a chronic demyelinating inflammatory disease of the central nervous system. T cell proliferation leads to the release of pro-inflammatory cytok...